Results 201 to 210 of about 299,590 (247)
Interleukins in COVID-19 and SARS-CoV-2 Variants: Immunopathogenesis, Therapeutic Perspectives and Vaccine-Induced Immune Responses. [PDF]
Int J Mol SciMahajan S, Mahajan S, Gusain A.
europepmc +1 more source
Signaling pathways in systemic lupus erythematosus and therapeutic implications. [PDF]
Front ImmunolBalogh L, Kovács VG, Nagy G, Németh T.
europepmc +1 more source
Cannabidiol reduces LPS-induced inflammatory response in the human placenta by reducing NF-κB translocation. [PDF]
J Cannabis ResPortillo R +8 more
europepmc +1 more source
Interleukin-6 Inhibitor-Induced Leukocytoclastic Vasculitis: A Case Report With a Literature Review. [PDF]
Case Reports ImmunolAloyan T +3 more
europepmc +1 more source
Fermented Foods and the Gut-Liver Axis: Modulation of MASLD Through Gut Microbiota. [PDF]
NutrientsWesołek-Leszczyńska A +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors
Journal of Neuro-Oncology, 1994Interleukin-6 (IL-6) is a multifunctional cytokine which plays a role in the stimulation, inhibition, differentiation, and regulation of cell growth. IL-6 has been shown to act as an autocrine growth factor in several tumors, and is expressed by a variety of tumors. IL-6 also exhibits a regulatory role in the hypothalamo-pituitary axis.
A R, Rezai +4 more
openaire +2 more sources
Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease
Neuroscience Letters, 1998Serum levels of interleukin-6 (IL-6) and interleukin-6 soluble receptor (IL-6sR) were measured in 41 patients (23 female and 18 male, mean age 72.5 years) with Alzheimer's disease (AD) and in 32 controls (14 women and 18 men, mean age 69.2 years) using enzyme-linked immunosorbent assays (ELISA).
P, Angelis +4 more
openaire +2 more sources